EnteroMedics is a development-stage medical device company focused on the design and development of devices that use neuroblocking technology to treat obesity and other gastrointestinal disorders. EnteroMedics' proprietary neuroblocking technology, VBLOC™ vagal blocking therapy, is designed to intermittently block the vagus nerves using high-frequency, low-energy, electrical impulses. The Food and Drug Administration recently granted EnteroMedics approval for a pivotal clinical study of the company’s investigational VBLOC Therapy as delivered by the Maestro™ System, its initial product for the treatment of obesity.

Contact Information

2800 Patton Road
St Paul, MN 55113

tel: 651-634-3003


Investor Relations



Exchange: NASDAQ
Industry: Medical Appliances & Equipment
Market Cap: $77.1M

The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.